Development of a bioconjugate vaccine against group b streptococcus

Ended Project Grant Awarded Last action

Award ID
R41AI142928
Recipient
Awarding agency
Obligated
$580,104

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Place of performance
St. Louis, MO 63110, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Amendment -$280,104 $0
Amendment $300,000 $0
Amendment $280,104 $0
Amendment -$300,000 $0
Amendment -$280,104 -$280,104
Amendment -$300,000 -$300,000
Amendment $300,000 $300,000
Amendment $280,104 $280,104
Amendment $280,104 $0
Amendment $0 $0
Original award $300,000 $0
Show all 13

Quick answers

Who received award R41AI142928?

R41AI142928 was awarded to Vaxnewmo by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 12, 2019.

How much is award R41AI142928 worth?

$580,104 has been obligated on R41AI142928.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award